186
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Mean Platelet Volume, Red Cell Distribution Width, and Complete Blood Cell Count Indices in Retinal Vein Occlusions

ORCID Icon, , , ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 39-47 | Received 09 Dec 2019, Accepted 28 Jun 2020, Published online: 10 Jul 2020

References

  • Clarkson JG. Central retinal vein occlusion. In: Ryan SJ, ed. Retina. Vol. 2: Medical Retina. 3rd ed. Mosby Inc.; 2001:1368–1375. St. Louis, Mo.
  • Fekrat S, Finkelstein D. Branch retinal vein occlusion. In: Ryan SJ, ed. Retina. Vol. 2: Medical Retina. 3rd ed. Mosby Inc.; 2001:1376–1381. St. Louis, Mo.
  • Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003;136:1136–1150.
  • Pinna A, Carru C, Solinas G, Zinellu A, Carta F. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion. Invest Ophthalmol Vis Sci. 2007;48:2747–2752.
  • Du J, Wang Q, He B, et al. Association of mean platelet volume and platelet count with the development and prognosis of ischemic and hemorrhagic stroke. Int J Lab Hematol. 2016;38:233–239.
  • Sahin M, Sahin A, Elbey B, Yüksel H, Türkcü FM, Cingü AK. Mean platelet volume in patients with nonarteritic anterior ischemic optic neuropathy. J Ophthalmol. 2016;2016:1051572.
  • Onder HI, Kilic AC, Kaya M, Bulur S, Onder E, Tunc M. Relation between platelet indices and branch retinal vein occlusion in hypertensive patients. Indian J Ophthalmol. 2013;61:160–162.
  • Sahin A, Sahin M, Yuksel H, et al. The mean platelet volume in patients with retinal vein occlusion. J Ophthalmol. 2013;2013:236371.
  • Yilmaz T, Yilmaz A. Altered platelet morphological parameters in patients with retinal vein occlusion. Eur Rev Med Pharmacol Sci. 2016;20:1934–1939.
  • Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002;13:301–306.
  • Paliogiannis P, Fois AG, Sotgia S, et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev. 2018;27(147):170113.
  • Paliogiannis P, Scognamillo F, Bellomo M, et al. Neutrophil to lymphocyte ratio as a predictor of thyroid papillary carcinoma. Acta Med Mediterr. 2015;31:371–375.
  • Dursun A, Ozturk S, Yucel H, et al. Association of neutrophil/lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol. 2015;25:343–346.
  • Central Vein Occlusion Study Group. Baseline and early natural history report. The central vein occlusion study. Arch Ophthalmol. 1993;111:1087–1095.
  • Turkseven Kumral E, Yenerel NM, Ercalik NY, Imamoglu S, Vural ET. Neutrophil/lymphocyte ratio and mean platelet volume in branch retinal vein occlusion. Saudi J Ophthalmol. 2016;30:105–108.
  • Ornek N, Ogurel T, Ornek K, Onaran Z. Mean platelet volume in retinal vein occlusion. Eur Rev Med Pharmacol Sci. 2014;18:2778–2782.
  • The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 1996;114:545–554.
  • The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol. 1993;116:286–296.
  • Giles H, Smith REA, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994;24:69–72.
  • McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology. 2009;116:1778–1787.e1.
  • Pinna A, Simula P, Zinellu A. Subcutaneous nadroparin calcium in the treatment of recent onset retinal vein occlusion: a pilot study. J Ocul Pharmacol Ther. 2012;28:448–454.
  • Hu ZD, Sun Y, Guo J, et al. Red blood cell distribution width and neutrophil/lymphocyte ratio are positively correlated with disease activity in primary Sjögren’s syndrome. Clin Biochem. 2014;47:287–290.
  • Lippi G, Plebani M. Red blood cell distribution width (RDW) and human pathology. One size fits all. Clin Chem Lab Med. 2014;52:1247–1249.
  • Paliogiannis P, Zinellu A, Mangoni AA, et al. Red blood cell distribution width in pregnancy: a systematic review. Biochem Med (Zagreb). 2018;28(3):030502.
  • Ozkok A, Nesmith BLW, Schaal S. Association of red cell distribution width values with vision potential in retinal vein occlusion. Ophthalmol Retina. 2018;2:582–586.
  • Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684–691.
  • Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res. 2008;78:8–17.
  • O’Donnell VB, Murphy RC, Watson SP. Platelet lipidomics: a modern day perspective on lipid discovery and characterization in platelets. Circ Res. 2014;114:1185–1203.
  • Bora K, Jitani AK, Raphael V, A Ruram, Borah P, Khonglah Y. Association between lipid profile and platelet indices: the importance of considering the influence of lipid profile while evaluating the clinical utility of platelet indices. Int J Lab Hematol. 2016;38:e80–3.
  • Fessler MB, Rose K, Zhang Y, Jaramillo R, Zeldin DC. Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population. J Lipid Res. 2013;54:3177–3188.
  • Lippi G, Danesse E, Mattiuzzi C, Montagnana M. Lack of association of the mean platelet volume with plasma lipids in a general population of unselected outpatients. Riv Ital Med Lab. 2014;10:97–101.
  • Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci Rep. 2017;7:16717.
  • Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134–146.
  • Fu H, Qin B, Hu Z, et al. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab. 2015;61:269–273.
  • Mertoglu C, Gunay M. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2017;11:S127–S131.
  • Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther. 2013;15:942–947.
  • Ilhan N, Daglioglu MC, Ilhan O, et al. Assessment of Neutrophil/Lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol Inflamm. 2015;23:287–290.
  • Kurtul BE, Ozer PA. The relationship between neutrophil-to-lymphocyte ratio and age-related macular degeneration. Korean J Ophthalmol. 2016;30:377–381.
  • Sengul EA, Artunay O, Kockar A, et al. Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration. Int J Ophthalmol. 2017;10:754–759.
  • Pinna A, Porcu T, D’Amico-Ricci G, et al. Complete blood cell count-derived inflammation biomarkers in men with age-related macular degeneration. Ocul Immunol Inflamm. 2019;27:932–93626.
  • Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:2703518.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.